Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Escin is a mixture of saponins derived from horse chestnut (Aesculus hippocastanum). It has been traditionally used for chronic venous insufficiency, but there is also scientific evidence supporting its use for vascular conditions such as thrombosis. Escin’s main pharmacological actions are anti-inflammatory, vasoprotective, and anti-edematous. Several preclinical studies have shown that escin can reduce vascular permeability, decrease inflammation, and inhibit leukocyte migration, all of which contribute to the prevention of venous stasis and thrombosis formation. Some clinical studies and meta-analyses have reported that escin can reduce symptoms of venous insufficiency and may lower the risk of postoperative thrombosis, especially in orthopedic and surgical patients. The proposed mechanisms include strengthening capillary walls, inhibiting the activity of enzymes like hyaluronidase and elastase, and improving venous tone. However, while the evidence suggests a potential benefit, most clinical trials focus on symptoms like leg swelling and pain rather than thrombosis as a primary endpoint. Furthermore, large, high-quality randomized controlled trials specifically assessing escin’s efficacy in preventing or treating thrombosis are lacking. Therefore, escin is supported by moderate scientific evidence for venous protection and prevention of thrombosis-related complications, but it is not a substitute for anticoagulant therapy in established thrombosis cases.

More about Escin
More about Thrombosis

Other ingredients used for Thrombosis

Other health conditions supported by Escin

Products containing Escin